Trial intelligence / Profile preview

Hemodynamic Effects of Levosimendan in Heart Failure

NCT00585104Phase 2Completed

Sponsor
University of Utah
Start
Sep 2006
Primary completion
Dec 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of levosimendan in heart failure (HF), sponsored by University of Utah. Started Sep 2006; status: completed.

02

Drugs

levosimendan
03

Conditions

heart failure (HF)

Beyond the preview

Go deeper on NCT00585104.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00585104.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call